Prem Watsa
Fairfax Financial Holdings
Prem Watsa Change Healthcare Inc stake
total: 291
Fairfax Financial Holdings CHNG trades
- Total transactions:
- 3
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 1
- Held since:
- 2021 Q1
- Held for:
- 4 quarters
- Latest activity:
- 2022 Q1
According to 2026 Q2 report, Prem Watsa doesn't hold any Change Healthcare Inc (CHNG) shares. To date, the estimated cost basis is nearly $22.09 for "buy" trades and estimated average "sell" price is $21.38. Fairfax Financial Holdings first purchased CHNG in 2021 Q1, initially acquiring 35,000 shares. Since the initial investment in Change Healthcare Inc (CHNG), Fairfax Financial Holdings has made 2 more transactions.
When did Prem Watsa sell Change Healthcare Inc (CHNG)?
Prem Watsa sold off the entire Change Healthcare Inc (CHNG) position in 2022 Q1.
When did Prem Watsa buy Change Healthcare Inc (CHNG)?
Prem Watsa first invested in Change Healthcare Inc (CHNG) in 2021 Q1 at the reported quarter-end price of $22.09 per share.
What's the cost basis of Fairfax Financial Holdings's CHNG stake?
The estimated cost basis for Change Healthcare Inc (CHNG) stake is around $22.09 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $22.09
- Weighted AVG sell price:
- $21.38
Prem Watsa's historical trades in Change Healthcare Inc
3 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q1
|
0.00%
|
0
|
$21.39
|
|
-100% (-33,700)
|
-0.02%
|
|
2021 Q3
|
0.02%
|
33,700
|
$20.92
|
$705,000
|
-3.71% (-1,300)
|
-0%
|
|
2021 Q1
|
0.03%
|
35,000
|
$22.09
|
$773,000
|
new
|
+0.03%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.